• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Prolactinoma in a 40-Year-Old Woman

Article

A 40-year-old woman with a history of amenorrhea complained of recent headaches and galactorrhea for the last 6 months. A neurologic work-up revealed bitemporal hemianopia, and a radiograph of the skull suggested an enlarged sella turcica. A large pituitary adenoma disclosed by an MRI and a serum prolactin level of 360 µg/L led to a diagnosis of prolactinoma.

A 40-year-old woman with a history of amenorrhea complained of recent headaches and galactorrhea for the last 6 months. A neurologic work-up revealed bitemporal hemianopia, and a radiograph of the skull suggested an enlarged sella turcica. A large pituitary adenoma disclosed by an MRI and a serum prolactin level of 360 µg/L led to a diagnosis of prolactinoma.

Prolactinoma is the most common pituitary adenoma. A serum prolactin level above 200 µg/L usually indicates this type of secretory tumor. In addition to causing headaches and compromising other pituitary hormone secretion, these tumors may grow and compress adjacent cranial nerves and lead to neurologic dysfunction.

Drs Sonia Arunabh and Navin Verma of Flushing, NY, report that this patient responded to bromocriptine, 10 mg/d. Within a month, regular menstrual periods resumed, and the intensity of the headaches diminished. Radiotherapy or surgical resection may be considered for macroadenomas that do not respond to bromocriptine therapy.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.